Years of research by Vanderbilt University Medical Center investigators to determine how precancerous cells in the stomach transition to gastric cancer and to develop strategies to prevent this transition have received federal funding to test two potential treatments. The $2.5 million Department of Defense Translational Team Science Award provides funding over four years to launch a […]
The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has awarded a $1 million grant to support research at Vanderbilt aimed at dramatically expanding the efficacy of immunotherapy for colorectal cancer. Currently, only people with microsatellite instability-high colorectal cancer, which accounts for about 10% of patients, respond to immune checkpoint inhibitors, but Vanderbilt researchers have […]
Data from a clinical trial shows that a dual immunotherapy regimen plus short-course radiation for the treatment of rectal cancer that is microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) can be effective enough to avoid chemotherapy and colostomy-requiring surgery. The data from the EA2201 study was so promising that the clinical trial is being […]
We have made great progress in recent decades with cures and better treatments for many cancers, but that has not been the case with gliomas — tumors that originate in the brain — and particularly glioblastoma, the most aggressive form. With the assistance and support of families who have been affected by gliomas, we are […]
